Consistently, WIP1 inhibition by GSK2830371 also increased the sensitivity of PARP inhibitors and promoted apoptosis in HCC cells (Fig. 6E–H, Additional file 1: Fig. 6E). This evidence concerns the gene PARP1 and hepatocellular carcinoma.